# Andrew Blauvelt

热门播客单集
已更新:

Ep. 213 "Psoriasis is More Than Body Surface Area"

Listen to this compelling discussion about when psoriasis should be considered severe and what that means for treatment choices in high impact areas like the scalp, nails, palms, soles, face, and genitalia with dermatologist Dr. Andrew Blauvelt, Investigator at Oregon Medical Research Center, Cha...

Scalp Psoriasis Treatment: Examining Deucravacitinib’s Efficacy and Safety

Guest: Andrew Blauvelt, MD, MBA As the only FDA-designated selective TYK2 inhibitor, deucravacitinib has emerged as a potential therapeutic option for scalp psoriasis. And after analyzing its impacts in a phase III clinical trial, it has continued to show promise in terms of both effic...

Episode 244: Beyond Symptom Control: Can We Achieve Deep Remission in Psoriasis?

In this episode, Jonathan Sackier welcomes Andrew Blauvelt, a distinguished dermatologist and leading expert in immunodermatology. They discuss groundbreaking advancements in psoriasis treatment, including the role of high-dose biologics in achieving deep remission and how IL-23 inhibition is tra...

Scalp Psoriasis Care: When Should Systemic Therapy Be Considered?

Guest: Andrew Blauvelt, MD, MBA While systemic therapies like deucravacitinib have previously only been recommended for patients with moderate-to-severe plague psoriasis, it may be worth questioning whether body surface area alone is enough to dictate its use. Learn when scalp psoriasi...

Future Directions in Psoriasis Treatment: Innovations and Implications

Guest: Andrew Blauvelt, MD, MBA From novel oral therapies to advancements in biologic injections, the treatment landscape for psoriasis is rapidly evolving. Here to share his insights on how these new treatment strategies could improve efficacy, reduce safety concerns, and even make on...

Ep. 251 "Managing Psoriasis in High Impact Sites is a Whole Different Ball Game"

Psoriasis in high impact sites like the scalp, nails, genitals, palms, and soles is challenging. Hear views on living with such difficult to treat areas, and how appropriate treatments offer patient centered care from internationally recognized dermatologist Dr. Andrew Blauvelt, chair of the NPF ...

#434/Author Volker Welter + Cranbrook's Andrew Blauvelt + Musical Guests Kathy and Gregg Gelb

Our first guest Volker Welter uncovers how architect Leopold Fischer fled Europe to shape Modernism in the US. We have Cranbrook Museum's Chief Curator Andrew Blauvelt, and later, musical guests Gregg and Kathy Gelb in a tribute to Paul Montgomery.

Beyond the Skin: Uncovering the Hidden Complexity of Psoriasis Care

This episode takes a deeper look at how clinicians navigate the real-world complexity of treating plaque psoriasis, moving far beyond textbook definitions of severity. Dr. Raj Bhardwaj sits down with leading dermatologist Dr. Andrew Blauvelt to unpack how early decisions, evolving guidelines, and...

Ep. 199 "TB Testing in the Era of IL‑17 and IL‑23 Inhibitors"

In this episode, Dr. Andrew Blauvelt and Dr. G. Scott Drew talk with NPF CSMO Dr. Guy Eakin about when—and whether—TB testing is needed before initiating psoriasis therapies. Listeners can read the NPF/IPC position paper referenced here: https://www.jaad.org/article/S0190-9622(25)03232-3/fulltext...

Psoriasis Climate Heats Up: Biosimilar Tsunami

Drs Steve Feldman and Andrew Blauvelt have a fascinating chat about contrasts and similarities between biologics and biosimilars, covering pharmacoeconomic and legal differences between the US and Europe. Relevant disclosures can be found with the episode show notes on Medscape (https://www.meds...